Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy (EGGSOTI)
This study has been completed.
Sponsor:
Ospedale Buon Consiglio Fatebenefratelli
Information provided by (Responsible Party):
Iride Dello Iacono, Ospedale Buon Consiglio Fatebenefratelli
ClinicalTrials.gov Identifier:
NCT01379651
First received: June 20, 2011
Last updated: September 19, 2011
Last verified: September 2011
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Results First Received: June 24, 2011
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Safety/Efficacy Study; Intervention Model: Single Group Assignment; Masking: Open Label; Primary Purpose: Treatment |
| Condition: |
- Egg Hypersensitivity |
| Intervention: |
Other: Specific oral tolerance induction |
Participant Flow
Recruitment Details
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| 26 children (14 boys, 12 girls; median age: 7 years 7 months; range 5-11 years), with severe IgE-mediated egg allergy (EA) were recruited from the Pediatric and Allergology Unit of the Fatebenefratelli Hospital in Benevento, Italy, from January 2008 to December 2009. |
Pre-Assignment Details
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| 6 children(4 males and 2 females)were excluded from the study: one child because the parents had a history of unreliable management of complications and treatments;2 children because of poorly controlled asthma;3 children because of a positive double-blind placebo-controlled food challenge (DBPCFC) at a dose of raw egg emulsion higher than 0.9 ml. |
Reporting Groups
| Description | |
|---|---|
| Specific Oral Tolerance Induction | Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen |
| Control | controls were kept on an egg-free diet for 6 months |
Participant Flow: Overall Study
| Specific Oral Tolerance Induction | Control | |
|---|---|---|
| STARTED | 10 | 10 |
| COMPLETED | 10 | 10 |
| NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Reporting Groups
| Description | |
|---|---|
| Specific Oral Tolerance Induction | Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen |
| Control | controls were kept on an egg-free diet for 6 months |
| Total | Total of all reporting groups |
Baseline Measures
| Specific Oral Tolerance Induction | Control | Total | |
|---|---|---|---|
|
Number of Participants
[units: participants] |
10 | 10 | 20 |
|
Age
[units: participants] |
|||
| <=18 years | 10 | 10 | 20 |
| Between 18 and 65 years | 0 | 0 | 0 |
| >=65 years | 0 | 0 | 0 |
|
Age
[units: years] Mean ± Standard Deviation |
7.033 ± 1.768 | 7.676 ± 3.203 | 7.354 ± 2.607 |
|
Gender
[units: participants] |
|||
| Female | 5 | 5 | 10 |
| Male | 5 | 5 | 10 |
|
Region of Enrollment
[units: participants] |
|||
| Italy | 10 | 10 | 20 |
Outcome Measures
| 1. Primary: | Number of Children That Achieved Total (40 ml) or Partial (Less Than 40 ml But at Least 10 ml) Tolerance to Raw Egg [ Time Frame: baseline and 6 months ] |
| 2. Secondary: | Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP [ Time Frame: Baseline and 6 months ] |
Hide Outcome Measure 2| Measure Type | Secondary |
|---|---|
| Measure Title | Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP |
| Measure Description | Before and after SOTI, we evaluated the change in the median weal diameter in millimeters, using egg white SPTs, end-point SPT and PP. |
| Time Frame | Baseline and 6 months |
| Safety Issue | Yes |
Population Description
| Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate. |
|---|
| We were unable to calculate sample size because no quantitative data about the clinical outcome could be hypothesized. Indeed, the few reports of food causing allergy, the protocol, the way of SOTI administration and food doses administered yielded reported variable results. the analysis was per intention to treat |
Reporting Groups
| Description | |
|---|---|
| Specific Oral Tolerance Induction | Specific oral tolerance induction consisted in the administration of increasing amounts of food antigen |
| Control | controls were kept on an egg-free diet for 6 months |
Measured Values
| Specific Oral Tolerance Induction | Control | |
|---|---|---|
|
Number of Participants Analyzed
[units: participants] |
10 | 10 |
|
Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP
[units: mm diameter] Median ( Full Range ) |
5
( 4 to 13 ) |
10
( 5.5 to 15 ) |
No statistical analysis provided for Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PP
More Information
Certain Agreements:
Limitations and Caveats
Results Point of Contact:
Publications:
| All Principal Investigators ARE employed by the organization sponsoring the study. |
Limitations and Caveats
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
Results Point of Contact:
Name/Title: Dr. Iride Dello Iacono
Organization: Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy
phone: +39 824 771111
e-mail: iridedello@hotmail.com
Organization: Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy
phone: +39 824 771111
e-mail: iridedello@hotmail.com
Publications:
| Responsible Party: | Iride Dello Iacono, Ospedale Buon Consiglio Fatebenefratelli |
| ClinicalTrials.gov Identifier: | NCT01379651 History of Changes |
| Other Study ID Numbers: | FBFBN |
| Study First Received: | June 20, 2011 |
| Results First Received: | June 24, 2011 |
| Last Updated: | September 19, 2011 |
| Health Authority: | Italy: National Institute of Health |